Search For

Progression of bone-metastatic prostate cancer in a mouse model treated with a novel pan-class I GLUT inhibitor (DRB18)

Stimulation of in vitro bone formation by canine prostate cancer

Leelamine suppresses cMyc expression in prostate cancer cells in vitro and inhibits prostate carcinogenesis in vivo

Could zinc dipicolinate be used to “smuggle” zinc into prostate cancer cells?

Deubiquitination in prostate cancer progression: role of USP22

Lectin-like transcript 1 as a natural killer cell-mediated immunotherapeutic target for triple negative breast cancer and prostate cancer

Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review

Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer

Mass spectrometry-based metabolomic profiling of prostate cancer - a pilot study

Increased ARF6 activation correlates with HGF stimulation in non-invasive prostate cancer cells

Introduction of the special issue “How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?”

Expression and regulation of aldehyde dehydrogenases in prostate cancer